Arthur Levin
Director/Board Member bei AVIDITY BIOSCIENCES, INC.
Vermögen: 7 Mio $ am 31.03.2024
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Troy Wilson | M | 55 | 12 Jahre | |
| Edward Kaye | M | 74 | 7 Jahre | |
| Sarah Boyce | F | 52 | 5 Jahre | |
| Seth Harrison | M | 63 | 9 Jahre | |
| Kathleen Gallagher | F | - | 3 Jahre | |
| Adrian Krainer | M | 65 | 10 Jahre | |
| Huw Nash | M | 57 | 10 Jahre | |
| Eric B. Mosbrooker | M | 46 | 3 Jahre | |
| John W. Wallen | M | 66 | 12 Jahre | |
| Carsten Boess | M | 57 | 4 Jahre | |
| Tamar Thompson | F | 50 | 3 Jahre | |
| Isabel Aznarez | M | 52 | 10 Jahre | |
| Noreen Henig | M | 59 | 5 Jahre | |
| Arthur Tzianabos | M | 60 | 6 Jahre | |
| Jennifer Burstein | F | 52 | 5 Jahre | |
| Jonathan Allan | M | - | - | |
| Michael MacLean | M | 58 | 4 Jahre | |
| Ian Smith | M | 58 | 1 Jahre | |
| Jean J. Kim | F | 50 | 3 Jahre | |
| Julie Smith | F | 53 | 4 Jahre | |
| Garry Menzel | M | 59 | 4 Jahre | |
| W. Flanagan | M | 62 | 3 Jahre | |
| Joan Wood | F | - | 5 Jahre | |
| Shamim Ruff | F | 64 | 6 Jahre | |
| Eric Rojas | M | - | - | |
| Bo Jesper Hansen | M | 66 |
Amylon Therapeutics BV
 Amylon Therapeutics BV Pharmaceuticals: MajorHealth Technology Amylon Therapeutics BV is a biopharmaceutical company, which engages in the research and development of therapies for the central nervous system. It specializes in ribonucleic acid modulation technology to target rare genetic disorders. The company was founded by Thomas de Vlaam and is headquartered in Leiden, the Netherlands. | - |
| Steven G. Hughes | M | 57 | 2 Jahre | |
| Barry Ticho | M | 64 | 7 Jahre | |
| Domenico Valerio | M | 67 |
Amylon Therapeutics BV
Amylon Therapeutics BV Pharmaceuticals: MajorHealth Technology Amylon Therapeutics BV is a biopharmaceutical company, which engages in the research and development of therapies for the central nervous system. It specializes in ribonucleic acid modulation technology to target rare genetic disorders. The company was founded by Thomas de Vlaam and is headquartered in Leiden, the Netherlands. | 7 Jahre |
| Teresa McCarthy | F | 60 | 4 Jahre | |
| Doug Snow | M | - | 3 Jahre | |
| Dawn Kalmar | F | 47 | 5 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Michael Martin | M | 50 | 5 Jahre | |
| Robin A. Walker | M | 55 | 1 Jahre | |
| Peter Hawryluk | M | 55 | 7 Jahre | |
| Christopher J. Morl | M | 65 |
miRagen Therapeutics, Inc. /Old/
 miRagen Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology miRagen Therapeutics, Inc. develops microRNA-based therapeutics for cardiovascular and muscle diseases. It leverages in-house expertise in miRNA biology, oligonucleotide chemistry, and drug development to evaluate and advance RNA-based technologies and potential drug candidates for its own pipeline and in strategic collaborations. The firm aso focuses on hematological malignancies, fibrosis and neuro inflammation. The company was founded by William S. Marshall, Michael R. Bristow, Marvin H. Caruthers, Bruce Lee Booth and Eric Newell Olson in 2007 and is headquartered in Boulder, CO. | 3 Jahre |
| Rod Wong | M | 47 | 2 Jahre | |
| Todd Brady | M | 45 | 5 Jahre | |
| Nancy M. Wyant | F | - | 5 Jahre | |
| Steve Bajan | M | - |
Muhlenberg College
| 4 Jahre |
| Meena | M | 51 | 4 Jahre | |
| Charles R. Allerson | M | 56 | 2 Jahre | |
| Gene Liau | M | 69 | 4 Jahre | |
| Martin Brenner | M | 54 | 1 Jahre | |
| Jae B. Kim | M | 55 | 1 Jahre | |
| Andrew J. Geall | M | - | - | |
| Tony Hsu | M | - | - | |
| Aimee L. Jackson | M | - |
miRagen Therapeutics, Inc. /Old/
miRagen Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology miRagen Therapeutics, Inc. develops microRNA-based therapeutics for cardiovascular and muscle diseases. It leverages in-house expertise in miRNA biology, oligonucleotide chemistry, and drug development to evaluate and advance RNA-based technologies and potential drug candidates for its own pipeline and in strategic collaborations. The firm aso focuses on hematological malignancies, fibrosis and neuro inflammation. The company was founded by William S. Marshall, Michael R. Bristow, Marvin H. Caruthers, Bruce Lee Booth and Eric Newell Olson in 2007 and is headquartered in Boulder, CO. | - |
| Mitchell Eisenberg | M | - |
Muhlenberg College
| 4 Jahre |
| Orin Levy | M | - |
Muhlenberg College
| 3 Jahre |
| Daniel Fisher | M | 67 |
Muhlenberg College
| 4 Jahre |
| Stephen Tulipano | M | 65 | 5 Jahre | |
| Jeffrey Goodman | M | 68 |
Muhlenberg College
| 4 Jahre |
| Richard A. Mitstifer | M | 66 |
Muhlenberg College
| 4 Jahre |
| Sam Hall | M | 42 | 5 Jahre | |
| Michael Pocalyko | M | 69 |
Muhlenberg College
| 4 Jahre |
| Sarah G. Avery | F | - |
Muhlenberg College
| 4 Jahre |
| Karl Bourdeau | M | - |
Muhlenberg College
| 4 Jahre |
| Richard Frederick Brueckner | M | 74 |
Muhlenberg College
| 4 Jahre |
| Terence S. Novak | M | 67 |
Muhlenberg College
| 4 Jahre |
| Raymond Schilling | M | - |
Muhlenberg College
| 4 Jahre |
| Joseph Baroldi | M | 46 | 2 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 36 | 58,06% |
| Niederlande | 2 | 3,23% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Arthur Levin
- Persönliches Netzwerk
